Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

386 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Minimally invasive tumor bed implant (MITBI) and peri-operative high-dose-rate brachytherapy (PHDRBT) for accelerated minimal breast irradiation (AMBI) or anticipated boost (A-PHDRBT-boost) in breast-conserving surgery for ductal carcinoma in situ.
Morales MG, Martinez-Regueira F, Rodriguez-Spiteri N, Olartecoechea B, Rubio I, Esgueva A, Pina L, Elizalde A, Sampedro CS, Idoate MA, Abengozar M, Ramos L, Manuel FC, Martínez-Monge R, Cambeiro M. Morales MG, et al. Among authors: rubio i. J Contemp Brachytherapy. 2020 Dec;12(6):521-532. doi: 10.5114/jcb.2020.101684. Epub 2020 Dec 16. J Contemp Brachytherapy. 2020. PMID: 33437299 Free PMC article.
Four-fraction ultra-accelerated minimal breast irradiation in early breast cancer: The initial feasibility results of an institutional experience.
Morales MG, Martínez-Monge R, Martínez-Regueira F, Rodriguez-Spiteri N, Olartecoechea B, Ramos L, Ayestarán A, Insausti LP, Elizalde A, Abengozar M, Rubio I, Esgueva A, Sobrido C, Cambeiro M. Morales MG, et al. Among authors: rubio i. Brachytherapy. 2022 Jul-Aug;21(4):475-486. doi: 10.1016/j.brachy.2022.01.008. Epub 2022 Apr 5. Brachytherapy. 2022. PMID: 35396137 Clinical Trial.
Surgical Management of the Axilla in Clinically Node-Positive Breast Cancer Patients Converting to Clinical Node Negativity through Neoadjuvant Chemotherapy: Current Status, Knowledge Gaps, and Rationale for the EUBREAST-03 AXSANA Study.
Banys-Paluchowski M, Gasparri ML, de Boniface J, Gentilini O, Stickeler E, Hartmann S, Thill M, Rubio IT, Di Micco R, Bonci EA, Niinikoski L, Kontos M, Karadeniz Cakmak G, Hauptmann M, Peintinger F, Pinto D, Matrai Z, Murawa D, Kadayaprath G, Dostalek L, Nina H, Krivorotko P, Classe JM, Schlichting E, Appelgren M, Paluchowski P, Solbach C, Blohmer JU, Kühn T, The Axsana Study Group. Banys-Paluchowski M, et al. Cancers (Basel). 2021 Mar 29;13(7):1565. doi: 10.3390/cancers13071565. Cancers (Basel). 2021. PMID: 33805367 Free PMC article. Review.
Localization Techniques for Non-Palpable Breast Lesions: Current Status, Knowledge Gaps, and Rationale for the MELODY Study (EUBREAST-4/iBRA-NET, NCT 05559411).
Banys-Paluchowski M, Kühn T, Masannat Y, Rubio I, de Boniface J, Ditsch N, Karadeniz Cakmak G, Karakatsanis A, Dave R, Hahn M, Potter S, Kothari A, Gentilini OD, Gulluoglu BM, Lux MP, Smidt M, Weber WP, Aktas Sezen B, Krawczyk N, Hartmann S, Di Micco R, Nietz S, Malherbe F, Cabioglu N, Canturk NZ, Gasparri ML, Murawa D, Harvey J. Banys-Paluchowski M, et al. Among authors: rubio i. Cancers (Basel). 2023 Feb 12;15(4):1173. doi: 10.3390/cancers15041173. Cancers (Basel). 2023. PMID: 36831516 Free PMC article. Review.
Local Treatment of Triple-Negative Breast Cancer.
Machiels M, Kaidar-Person O, Rubio IT, Poortmans P. Machiels M, et al. Cancer J. 2021 Jan-Feb 01;27(1):32-40. doi: 10.1097/PPO.0000000000000496. Cancer J. 2021. PMID: 33475291 Review.
386 results